Quality criteria for therapeutic lyophilisates
Lyophilization of pharmaceutical and biopharmacetical products
Article REF: PHA2026 V1
Quality criteria for therapeutic lyophilisates
Lyophilization of pharmaceutical and biopharmacetical products

Author : Alain HEDOUX

Publication date: September 10, 2013, Review date: February 12, 2021 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

5. Quality criteria for therapeutic lyophilisates

In order to market the product, the freeze-drying cycle must be validated, by inspecting the freeze-dried product for certain criteria, which must meet set standards. The most important of these in the pharmaceutical field are listed below.

These standards vary according to the active ingredient (e.g. color, dissolution time, etc.) and are set by laboratories in specifications.

5.1 Physical state of lyophilisate

The physical state of the product depends essentially on the freezing phase, which results in a dry product in a crystalline or amorphous state. Either form may affect the reconstitution procedure and/or the drug's solubility. The stability of the active ingredient during storage generally...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Ongoing reading
Quality criteria for therapeutic lyophilisates

Article included in this offer

"Drugs and pharmaceuticals"

( 125 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details
Contact us